Pear related stories
All articles and analysis
Moderna co-founder collects $77.5m for T.Rx CapitalLPs include “individual founders” from Arch Venture Partners, Lux Capital, Polaris Partners, Third Rock Ventures.
Origin Ventures' new partner eyes consumer companies' growth prospectsJacquie Marshall Siegmund isn't shy about calling a company she's a customer of and asking how they're financed. She helped pre-empt a deal at one before Origin invested in it.
Biotech firm Valar Labs takes in $22m Series ADCVC and Andreessen Horowitz led the round with participation from Pear VC.
Two dozen women-led funds defy the oddsWe crunched the data we’ve been collecting about women-led firms and found that they have closed on a combined $1.8bn for 24 funds so far this year.
Pear's secret to success: Do one thing really wellPear is made up of 'some of the hardest working VCs I’ve ever met,' says Joanna Rupp, who manages the $2.8bn PE portfolio for the University of Chicago's endowment.
DoorDash-backer Pear VC closes largest fund to dateInvestors in previous Pear funds include the Inasmuch Foundation, Los Angeles Fire & Police Pension System, the Richard King Mellon Foundation and the Passport Foundation, according to Venture Capital Journal research.
Canonical Crypto collects $20m for debut fundThe firm expects to make 40 to 50 investments, ranging from $250,000 to $500,000, from its first fund.
- Pear VC leads seed round for Sudozi
Sudozi, a financial software company, has raised $4.3 million in seed funding.
- Neura Health scores $2.2m
Neura Health, a telehealth company, has raised $2.2 million in funding.
Pear Therapeutics to go public via merger with Thimble Point SPACPear Therapeutics, a developer of prescription digital therapeutics, has agreed to go public via a merger with Thimble Point Acquisition Corp, a blank check company whose management team is associated with the Pritzker Vlock Family Office.